References
- Brennan M F, Casper E S, Harrison L B, Shiu M H, Gaynor J, Hajdu S I. The role of multimodality therapy is soft-tissue sarcoma. Ann Surg 1991; 214: 328–338
- Collin C, Godbold J, Hajdu S, Brennan M. Localized extremity soft tissue sarcoma: An analysis of factors affecting survival. J Clin Oncol 1987; 5: 601–612
- Gaynor J, Tan C, Casper E S, Collin C, Freidrich C, Shiu M, Hajdu S, Brennan M. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 1992; 109: 1317–1329
- Potter D A, Glenn J, Kinsella T, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985; 3: 353–366
- McCormack P M, Martini N. The changing role of surgery for pulmonary metastases. Ann Thorac Surg 1979; 28: 139–145
- Joseph W L, Morton D L, Adkins P C. Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg 1971; 61: 23–32
- Putnam J B, Jr., Roth J A, Wesley M N, Johnston M R, Rosenberg S A. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcoma. J Thorac Cardiovasc Surg 1984; 87: 260–268
- Mazanet R, Antman K H. Sarcomas of soft tissue and bone. Cancer 1991; 68: 463–473
- Lanza L A, Putnam J B, Jr., Benjamin R S, Roth J A. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991; 51: 219–224
- Dippold W, Lloyd K O, Li L TC, et al. Cell surface antigens of human malignant melanoma. Proc Natl Acad Sci USA 1980; 77: 6114–6118
- Houghton A N, Mintzer D, Cordon-Cardo C, et al. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 1985; 82: 1242–1246
- Chang H R, Brennan M F, Cheung N-K V, Hiroo Y, Houghton A N. Disialogangliosides GD2 and GD3 on human soft tissue sarcomas. Target antigens for antibody-mediated tumor cell lysis. Proc Am Assoc Cancer Res 1989; 30: 397
- Cordon-Cardo C, Lloyd K O, Finstad C L, et al. Immunoanatomic distribution of blood group antigens in the human urinary tract. Lab Invest 1986; 55: 444–454
- Vadhan-Raj S, Cordon-Cardo C, Carswell E, et al. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: Induction of inflammatory responses at tumor sites. J Clin Oncol 1988; 6: 1638–1648
- Chang H R, Cordon-Cardo C, Houghton A N, Cheung N-K V, Brennan M F. Expression of disialogangliosides GD2 and GD3 by human soft tissue sarcomas. Cancer 1992; 70: 633–638